Pioglitazone and risk of bladder cancer: Clarification of the design of the French study. Reply to Perez at [letter]

Diabetologia

Volumn 56, Issue 1, 2013, Pages 228-229

  Neumann, A ^a   Weill, A ^a   Ricordeau, P ^a   Fagot, J P ^a   Alla, F ^a   Allemand, H ^a  

^a Caisse Nationale d'Assurance Maladie des Travailleurs Salaries   (France)

Author keywords

Adverse effects; Bladder cancer; Cohort; France; Pharmacoepidemiology; Pioglitazone; Reimbursement database

Indexed keywords

PIOGLITAZONE;

BLADDER CANCER; CANCER INCIDENCE; CANCER RISK; DIABETES MELLITUS; DIABETIC PATIENT; FRANCE; HUMAN; LETTER; PRIORITY JOURNAL; SMOKING;

DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; THIAZOLIDINEDIONES; URINARY BLADDER NEOPLASMS;

EID: 84871612850     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2769-9     Document Type: Letter

References (7)

1. Perez AT (2012) Pioglitazone and risk of bladder cancer: clarification of the design of the French study. Diabetologia. doi: 10.1007/s00125-012-2767-y
2. Neumann A, Weill A, Ricordeau P, Fagot JP, Alla F, Allemand H (2012) Pioglitazone and risk of bladder cancer among diabetic patients in France: a population-based cohort study. Diabetologia 55:1953-1962
3. Bélot A, Velten M, Grosclaude P et al. (2008) [National estimate of the incidence and mortality from cancer in France between 1980 and 2005]. Saint-Maurice (Fra), Institut de veille sanitaire. Available from www.invs.sante.fr/publications/2009/estimation-cancer-1980-2005/ estimation-cancer-1980-2005.pdf, accessed 10 September 2012 [article in French]
4. Azoulay L, Yin H, Filion KB et al. (2012) The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study. BMJ 344:e3645
5. Colmers IN, Bowker SL, Majumdar SR, Johnson JA (2012) Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis. CMAJ 184:E675-E683
6. Mamtani R, Haynes K, Bilker WB et al. (2012) Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. J Natl Cancer Inst 104:1411-1421
7. Caisse nationale de l'assurance maladie (2011) Risque de cancer de la vessie chez les personnes diabétiques traitées par pioglitazone en France: une étude de cohorte sur les donnée du SNIIRAM et du PMSI. Available at http://ansm.sante.fr/content/download/34024/445581/version/1/ file/RapportEtudeCNAMTS-Pioglitazone-juin-20113.pdf, accessed 9 June 2011 [article in French]